Immune-mediated hemolytic anemia and thrombocytopenia in a foal.

The research article discusses a case of a one-month-old foal that was diagnosed with immune-mediated hemolytic anemia and thrombocytopenia, and its successful treatment which involved glucocorticoids, antibiotics, and a blood transfusion.

Clinical Presentation of the Foal

The paper begins by detailing the symptoms presented by the one-month-old Quarter Horse filly. These included:

• Unilateral epistaxis (nosebleeding)
• Hyphema (blood in the eye’s anterior chamber)
• Icterus (jaundice, characterized by yellowing of the skin)
• Petechial hemorrhages in her oral, nasal, conjunctival, and vulvar mucous membranes (red or purple spots caused by bleeding into the skin)
• Anemia (a lack of healthy red blood cells in the body)
• Thrombocytopenia (a low level of platelets in the blood, which help with clotting)

Diagnostic Tests

To make the correct diagnosis, several tests were run. Importantly, the filly had:

• A negative antinuclear test result, which indicate that the patient does not have an autoimmune disease
• A positive direct Coombs’ test result, indicating the presence of autoimmune hemolytic anemia where the body’s immune system mistakenly attacks its own red blood cells
• The absence of megakaryocytes or cell-associated IgG in bone marrow biopsy specimens, excluding natural bone marrow processes related to blood cell production or immune response

Treatment and Follow-up

Upon diagnosis, the foal was treated with:

• Glucocorticoids, which are used to suppress immune response in the case of autoimmune diseases
• Antibiotics, to prevent or treat any potential bacterial infections
• A single whole blood transfusion, to increase the number of healthy red blood cells and platelets in the patient’s body

The treatment was successful and the foal responded well, with no recurrence of the disease. A follow-up one year later confirmed that the foal was still clinically normal.